Celtic Therapeutics sets up $50 million Swiss ADC company - The Pharma Letter PDF Print

Keywords: Celtic Thera, ADC Thera, Spirogen, Multiple cancer indications, Antibody-drug-conjugates, Swiss company

Article | 26 March 2012

USA-based private equity firm Celtic Therapeutics Management has announced a significant commitment to antibody-drug-conjugate (ADC) products, with the launch of ...

Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.